Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Investigational

Study of Efgartigimod for Adults with Thyroid Eye Disease

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Haematological malignancy+1

Not recruiting

Registered drugNo placebo

Study of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drugNo placebo

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Danazol

Contact Research Centre

Find therapies in clinical trials near you – page 20

342 trials match your criteria

Malignant melanoma

Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

Transitional cell carcinoma

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Non-small cell lung cancer metastatic

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Haemophagocytic lymphohistiocytosis

Study of emapalumab in children and adults with Macrophage Activation Syndrome (MAS) occurring in Still's Disease or Systemic Lupus Erythematosus

Plasma cell myeloma

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Plasma cell myeloma refractory

Study of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy

Asthma

Long-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials

Hypertriglyceridaemia

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Endocrine ophthalmopathy

Study of Efgartigimod for Adults with Thyroid Eye Disease

Haematological malignancy+1

Study of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers

Triple negative breast cancer

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Myelofibrosis+1

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.